未登录 Perineural Invasion and Survival in Pembrolizumab-Treated Head and Neck Squamous Cell Carcinoma 周围神经侵犯与接受帕博利珠单抗治疗头颈部鳞状细胞癌患者的生存情况 [J] Truong, Angeline A.; Ho, Savinnie; Lee, Rex H.; Wu, Xin; Kang, Hyunseok; El-sayed, Ivan H.; George, Jonathan R.; Heaton, Chase M.; Likhterov, Ilya; Xu, Mary Jue; Ha, Patrick K.; Algazi, Alain P.; Wai, Katherine C. 分享 收藏
分享 收藏
Gemcitabine, carboplatin, and Epstein-Barr virus-specific autologous cytotoxic T lymphocytes for recurrent or metastatic nasopharyngeal carcinoma: VANCE, an international randomized phase III trial Toh, H. C.; Yang, M. -h.; Wang, H. -m.; Hsieh, C. Y.; Chitapanarux, I.; Ho, K. F.; Hong, R. -l.; Ang, M. K.; Colevas, A. D.; Sirachainan, E.; Lertbutsayanukul, C.; Ho, G. F.; Nadler, E.; Algazi, A.; Lulla, P.; Wirth, L. J.; Wirasorn, K.; Liu, Y. C.; Ang, S. F.; Low, S. H. J.; Tho, L. M.; Hasbullah, H. H.; Brenner, M. K.; Wang, W. -w.; Ong, W. S.; Tan, S. H.; Horak, I.; Ding, C.; Myo, A.; Samol, J. 分享 收藏
分享 收藏
N17350 kills cancer cells, spares immune cells, and regresses CDX tumors from chemotherapy naive and experienced patients Cui, Chang; Gujar, Ravindra; Lee, Christine; Fumagalli, Maria; Martinez, Nicole; Liu, Hannah; Grigaitis, Nicole; Feau, Sonia; Bahador, Afshin; Algazi, Alain P.; Becker, Lev 分享 收藏
A phase 1 study of triple-targeted therapy with BRAF, MEK, and AKT inhibitors for patients with BRAF-mutated cancers Algazi, Alain P.; Moon, James; Lao, Christopher D.; Chmielowski, Bartosz; Kendra, Kari L.; Lewis, Karl D.; Gonzalez, Rene; Kim, Kevin; Godwin, John E.; Curti, Brendan D.; Latkovic-Taber, Michaella; Lomeli, Shirley H.; Gufford, Brandon T.; Scumpia, Philip O.; Lo, Roger S.; Othus, Megan; Ribas, Antoni 分享 收藏
Comparison of intracranial (IC) response assessment criteria in patients (pts) with melanoma brain metastases (MBM) treated with combination nivolumab (NIVO) plus ipilimumab (IPI) in CheckMate 204 Huang, R.; Youssef, G.; Nelson, T.; Wen, P.; Forsyth, P.; Hodi, F. S.; Margolin, K. A.; Algazi, A. P.; Hamid, O.; Lao, C. D.; Ernstoff, M. S.; Moschos, S. J.; Atkins, M. B.; Postow, M.; Reardon, D. A.; Grootendorst, D. J.; Askelson, M.; Ritchings, C.; Tawbi, H. A. 分享 收藏
Pembrolizumab monotherapy versus chemotherapy in platinum-pretreated, recurrent or metastatic nasopharyngeal cancer (KEYNOTE-122): an open-label, randomized, phase III trial Pembrolizumab单药治疗与化疗在铂类预处理，复发或转移性鼻咽癌中的比较 (KEYNOTE-122): 一项开放标签，随机，III期试验 Chan, A. T. C.; Lee, V. H. F.; Hong, R-L; Ahn, M. -J.; Chong, W. Q.; Kim, S. -B.; Ho, G. F.; Caguioa, P. B.; Ngamphaiboon, N.; Ho, C.; Aziz, M. A. S. A.; Ng, Q. S.; Yen, C. -J.; Soparattanapaisarn, N.; Ngan, R. K. -C; Kho, S. K.; Tiambeng, M. L. A.; Yun, T.; Sriuranpong, V.; Algazi, A. P.; Cheng, A.; Massarelli, E.; Swaby, R. F.; Saraf, S.; Yuan, J.; Siu, L. L. 分享 收藏
Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 study pembrolizumab单药治疗2期158研究中晚期甲状腺癌患者的疗效和安全性 Oh, Do-Youn; Algazi, Alain; Capdevila, Jaume; Longo, Federico; Miller, Jr Wilson; Bing, Jerry Tan Chun; Eduardo Bonilla, Carlos; Chung, Hyun Cheol; Guren, Tormod K.; Lin, Chia-Chi; Motola-Kuba, Daniel; Shah, Manisha; Hadoux, Julien; Yao, Lili; Jin, Fan; Norwood, Kevin; Lebellec, Loic 分享 收藏
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors Naing, Aung; Algazi, Alain P.; Falchook, Gerald S.; Creelan, Benjamin C.; Powderly, John; Rosen, Seth; Barve, Minal; Mettu, Niharika B.; Triozzi, Pierre L.; Hamm, John; Zhou, Gongfu; Walker, Chris; Dong, Zhiwan; Patel, Manish R. 分享 收藏
Successful Anti-PD-1 Cancer Immunotherapy Requires T Cell-Dendritic Cell Crosstalk Involving the Cytokines IFN-γ and IL-12 (vol 49, 1148.e1, 2018) 成功的Anti-PD-1癌症免疫疗法需要涉及细胞因子ifn-γ 和IL-12的T细胞-树突状细胞串扰 (vol 49，1148.e1，2018) Garris, Christopher S.; Arlauckas, Sean P.; Kohler, Rainer H.; Trefny, Marcel P.; Garren, Seth; Piot, Cecile; Engblom, Camilla; Pfirschke, Christina; Siwicki, Marie; Gungabeesoon, Jeremy; Freeman, Gordon J.; Warren, Sarah E.; Ong, SuFey; Browning, Erica; Twitty, Christopher G.; Pierce, Robert H.; Le, Mai H.; Algazi, Alain P.; Daud, Adil I.; Pai, Sara I.; Zippelius, Alfred; Weissleder, Ralph; Pittet, Mikael J. 分享 收藏
Amplification of the CXCR3/CXCL9 axis via intratumoral electroporation of plasmid CXCL9 synergizes with plasmid IL-12 therapy to elicit robust anti-tumor Lee, Jack Y.; Nguyen, Bianca; Mukhopadhyay, Anandaroop; Han, Mia; Zhang, Jun; Gujar, Ravindra; Salazar, Jon; Hermiz, Reneta; Svenson, Lauren; Browning, Erica; Lyerly, H. Kim; Canton, David A.; Fisher, Daniel; Daud, Adil; Algazi, Alain; Skitzki, Joseph; Twitty, Christopher G. 分享 收藏
Intratumoral Electroporation of Plasmid Encoded IL12 and Membrane-Anchored Anti-CD3 Increases Systemic Tumor Immunity Han, Mia; Nguyen, Bianca; Lee, Jack Y.; Browning, Erica; Zhang, Jun; Mukhopadhyay, Anandaroop; Gujar, Ravindra; Salazar, Jon; Hermiz, Reneta; Svenson, Lauren; Rolig, Annah S.; Redmond, William L.; Algazi, Alain P.; Daud, Adil I.; Canton, David A.; Twitty, Christopher G. 分享 收藏
CheckMate 204: 3-year outcomes of treatment with combination nivolumab (NIVO) plus ipilimumab (IPI) for patients (pts) with active melanoma brain metastases (MBM) Tawbi, H. A.; Forsyth, P. A.; Hodi, F. S.; Algazi, A.; Hamid, O.; Lao, C. D.; Moschos, S. J.; Atkins, M. B.; Lewis, K.; Postow, M. A.; Thomas, R. P.; Khushalani, N. I.; Pavlick, A. C.; Ernstoff, M. S.; Reardon, D. A.; Chung, C.; Lee, W.; Bas, T.; Askelson, M.; Margolin, K. A. 分享 收藏
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma (vol 11, 6262, 2020) Ribas, Antoni; Algazi, Alain; Ascierto, Paolo A.; Butler, Marcus O.; Chandra, Sunandana; Gordon, Michael; Hernandez-Aya, Leonel; Lawrence, Donald; Lutzky, Jose; Miller, Wilson H., Jr.; Campbell, Katie M.; Delafont, Bruno; Marshall, Shannon; Mueller, Nancy; Robert, Caroline 分享 收藏
Safety and efficacy of the combination of nivolumab plus ipilimumab in patients with melanoma and asymptomatic or symptomatic brain metastases (CheckMate 204) nivolumab联合ipilimumab在黑色素瘤和无症状或有症状脑转移患者中的安全性和有效性 (CheckMate 204) Tawbi, Hussein A.; Forsyth, Peter A.; Hodi, F. Stephen; Lao, Christopher D.; Moschos, Stergios J.; Hamid, Omid; Atkins, Michael B.; Lewis, Karl; Thomas, Reena P.; Glaspy, John A.; Jang, Sekwon; Algazi, Alain P.; Khushalani, Nikhil, I; Postow, Michael A.; Pavlick, Anna C.; Ernstoff, Marc S.; Reardon, David A.; Puzanov, Igor; Kudchadkar, Ragini R.; Tarhini, Ahmad A.; Sumbul, Anne; Rizzo, Jasmine, I; Margolin, Kim A. 分享 收藏
PD-L1 blockade in combination with inhibition of MAPK oncogenic signaling in patients with advanced melanoma Ribas, Antoni; Algazi, Alain; Ascierto, Paolo A.; Butler, Marcus O.; Chandra, Sunandana; Gordon, Michael; Hernandez-Aya, Leonel; Lawrence, Donald; Lutzky, Jose; Miller, Wilson H., Jr.; Campbell, Katie M.; Delafont, Bruno; Marshall, Shannon; Mueller, Nancy; Robert, Caroline 分享 收藏
EARLY SAFETY AND EFFICACY OF A PHASE 1/2 OPEN-LABEL, MULTI-CENTER TRIAL OF SNS-301 ADDED TO PEMBROLIZUMAB IN PATIENTS WITH ADVANCED SQUAMOUS CELL CARCINOMA OF THE HEAD AND NECK (SCCHN) Algazi, Alain; Smith, William; Panella, Timothy; Shin, Dong; Fjaellskog, Marie-Louise; Celebi, John; Drumheller, Alice; Campbell, Jean; Pierce, Robert; Guarino, Michael 分享 收藏
Continuous versus intermittent BRAF and MEK inhibition in patients withBRAF-mutated melanoma: a randomized phase 2 trial Algazi, Alain P.; Othus, Megan; Daud, Adil, I; Lo, Roger S.; Mehnert, Janice M.; Thach-Giao Truong; Conry, Robert; Kendra, Kari; Doolittle, Gary C.; Clark, Joseph, I; Messino, Michael J.; Moore, Dennis F., Jr.; Lao, Christopher; Faller, Bryan A.; Govindarajan, Rangaswamy; Harker-Murray, Amy; Dreisbach, Luke; Moon, James; Grossmann, Kenneth F.; Ribas, Antoni 分享 收藏
Tilsotolimod engages the TLR9 pathway to promote antigen presentation and type I IFN signaling in solid tumours Babiker, H.; Borazanci, E.; Subbiah, V.; Algazi, A. P.; Schachter, J.; Lotem, M.; Hendler, D.; Rahimian, S.; Minderman, H.; Haymaker, C.; Bernatchez, C.; Murthy, R.; Hultsch, R.; Caplan, N.; Woodhead, G. J.; Hennemeyer, C. T.; Chunduru, S.; Anderson, P.; Diab, A.; Puzanov, I. 分享 收藏
.png){kind=icon}
未登录.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
